These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7410393)

  • 1. Effect of photooxidation on the estrogen receptor from rat mammary tumor.
    Feldman M; Kallos J; Hollander VP
    J Biol Chem; 1980 Sep; 255(18):8776-9. PubMed ID: 7410393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of chromatofocusing to distinguish estradiol receptor from ovarian-dependent and -independent rat mammary tumors.
    Coufalik AH; Feldman M; Platica M; Toth L; Dreiling D; Hollander VP
    Cancer Res; 1983 Nov; 43(11):5235-9. PubMed ID: 6616460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol binding in ovariectomy-responsive and -nonresponsive rat mammary carcinoma.
    Diamond EJ; Giladi M; Khan S; Hollander VP
    Cancer Res; 1977 Jun; 37(6):1852-6. PubMed ID: 870188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biological significance of estradiol receptor binding to DNA.
    Khan S; Feldman M; Hollander VP
    Cancer Res; 1980 Apr; 40(4):1050-3. PubMed ID: 7357535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel.
    Wrange O; Nordenskjöld B; Gustafsson JA
    Anal Biochem; 1978 Apr; 85(2):461-75. PubMed ID: 565601
    [No Abstract]   [Full Text] [Related]  

  • 6. The ether-catalyzed dissociation rate of estradiol-receptor complex distinguishes between hormone-sensitive and resistant rat mammary tumors.
    Hollander VP; Khan S
    J Steroid Biochem; 1980 Jan; 12():131-4. PubMed ID: 6252377
    [No Abstract]   [Full Text] [Related]  

  • 7. Nuclear translocation of the estrogen receptor in autonomous C3H mouse mammary tumors.
    Vignon F; Rochefort H
    Cancer Res; 1978 Jun; 38(6):1808-14. PubMed ID: 647690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA inhibits estrogen receptor binding to DNA.
    Feldman M; Kallos J; Hollander VP
    J Biol Chem; 1981 Feb; 256(3):1145-8. PubMed ID: 7451496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characteristic binding of catechol estrogens to estrogen receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Tanaka T; Katoh M; Kubodera A
    Steroids; 1986; 48(5-6):361-8. PubMed ID: 2832979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluctuations in levels of cytosol and nuclear estrogen receptors in rat mammary tumors during the estrous cycle.
    Shih A; Lee C
    Endocrinology; 1978 Feb; 102(2):420-5. PubMed ID: 570481
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphorylation and estradiol binding of estrogen receptor in hormone-dependent and hormone-independent GR mouse mammary tumors.
    Migliaccio A; Pagano M; De Goeij CC; Di Domenico M; Castoria G; Sluyser M; Auricchio F
    Int J Cancer; 1992 Jul; 51(5):733-9. PubMed ID: 1612782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased DNA binding of the estrogen receptor in an estrogen-resistant mammary cancer.
    Baskevitch PP; Vignon F; Bousquet C; Rochefort H
    Cancer Res; 1983 May; 43(5):2290-7. PubMed ID: 6403233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammary cancer: selective action of the estrogen receptor complex.
    Ip M; Milholland RJ; Rosen F; Kim U
    Science; 1979 Jan; 203(4378):361-3. PubMed ID: 760195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple modification of the estrogen receptor exchange assay: validation in nuclei from the rat uterus and a mouse mammary tumor.
    Schoenberg DR; Clark JH
    Endocrinology; 1980 Jan; 106(1):56-60. PubMed ID: 7349972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization by chromatofocusing of estrogen receptors from rat mammary tumor MTW9.
    Platica M; Doody J; Platica O; Cryan JG; Hollander VP
    J Natl Cancer Inst; 1989 Jul; 81(14):1093-6. PubMed ID: 2738939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of estrogen binding sites in mammary tumors.
    Clark JH; Watson CS; Markaverich BM; Syne JS; Panko WB
    Breast Cancer Res Treat; 1983; 3(1):61-5. PubMed ID: 6871482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of catechol estrogens to the estrogen receptor of dimethylbenz(A) anthracene induced rat mammary tumors.
    Abul-Hajj YJ
    J Steroid Biochem; 1980 Jan; 13(1):83-8. PubMed ID: 6770198
    [No Abstract]   [Full Text] [Related]  

  • 18. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
    Markaverich BM; Roberts RR; Alejandro MA; Clark JH
    Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid metabolism and steroid receptors in dimethylbenz(a)anthracene-induced rat mammary tumors.
    Eechaute W; de Thibault de Boesinghe L; Lacroix E
    Cancer Res; 1983 Sep; 43(9):4260-5. PubMed ID: 6409401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP-binding protein and estrogen receptor: antagonism during nuclear translocation in a hormone-dependent mammary tumor.
    Bodwin JS; Hirayama PH; Cho-Chung YS
    Biochem Biophys Res Commun; 1981 Dec; 103(4):1349-55. PubMed ID: 6277332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.